Skip to content

The Effect of Devdarvyadi dhoomra in Tobacco Smoking Withdrawal Syndrome

A Clinical Study To Evaluate the Efficacy of Devdarvyadi Dhoomra in Tobacco Smoking Withdrawal Syndrome - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069089
Enrollment
30
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J705- Respiratory conditions due to smoke inhalation

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patient of tobacco smoking addiction only. Clinical manifestation of tobacco smoking withdrawal patient including craving for nicotine anxiety depression restlessness Patient having history of Tobacco smoking more than 1 year Either sex Patient having Fagerstrom for Nicotine Dependence score ranging 5 to 10

Exclusion criteria

Exclusion criteria: Tobacco smoking addicted patient suffering from cancer Tobacco smoking addicted patient who are suffering from major psychiatric disorders Tobacco smoking addicted patients suffering from major systemic illness like myocardial infraction ischemic heart disease pulmonary tuberculosis diabetes mellitus hypertension Patient having Fagerstrom for Nicotine Dependence score ranging 0 to 4

Design outcomes

Primary

MeasureTime frame
Changes in clinical manifestation of Tobacco smoking withdrawal syndrome on the basis of DSM 5 criteriaTimepoint: 45 days

Secondary

MeasureTime frame
Changes in Liver Function Test, Lipid profile Changes in Spirometry Volume and CapacityTimepoint: 45 days

Countries

India

Contacts

Public ContactShubhangi Sharma

National Institute of Ayurveda

anita31sharma@yahoo.com9414078563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026